TABLE 6.
HIV+/TB+ |
HIV+/TB− |
||||
---|---|---|---|---|---|
Unweighted, n | Weighted % (95% CI) |
Unweighted, n | Weighted % (95% CI) |
P | |
Knowledge of HIV+ status | <0.0001 | ||||
Aware of HIV+ | 59 | 77.2 (66.8 to 87.6) | 238 | 42.9 (36.9 to 48.8) | |
Not aware | 16 | 22.8 (12.4 to 33.2) | 320 | 57.1 (51.2 to 63.1) | |
Total | 75 | 538 | |||
Care and treatment among those aware of HIV+ status | <0.0001 | ||||
Aware of HIV+, in care and on ART | 56 | 95.7 (92.0 to 99.4) | 144 | 61.2 (54.8 to 67.6) | |
Aware of HIV+, in care and not on ART | 3 | 4.3 (0.6 to 8.0) | 71 | 28.6 (22.5 to 34.7) | |
Aware of HIV+, not in care and not on ART | 0 | — | 23 | 10.2 (6.6 to 13.8) | |
Total | 59 | 238 | |||
Care and treatment among all persons HIV+ | <0.0001 | ||||
Aware of HIV+, in care and on ART | 56 | 73.9 (63.4 to 84.3) | 144 | 26.2 (21.3 to 31.1) | |
Aware of HIV+, in care and not on ART | 3 | 3.3 (0.5 to 6.2) | 71 | 12.3 (9.0 to 15.5) | |
Aware of HIV+, not in care and not on ART | 0 | — | 23 | 4.4 (2.8 to 6.0) | |
Not aware of HIV+ | 16 | 22.8 (12.4 to 33.2) | 320 | 57.1 (51.2 to 63.1) | |
Total | 75 | 558 | |||
Coverage of ART among persons aware of HIV+, in care, and eligible for ART* |
<0.0001 | ||||
In care and on ART | 29 | 100† | 80 | 88.6 (81.6 to 95.7) | |
In care and not on ART | 0 | — | 8 | 11.4 (4.3 to 18.4) | |
Total | 29 | 88 | |||
Coverage of ART among all persons HIV+ and eligible for ART* |
<0.0001 | ||||
In care and on ART | 29 | 86.9 (74.2 to 99.5)† | 80 | 58.3 (47.6 to 69.0) | |
In care and not on ART | 0 | — | 8 | 7.5 (2.8 to 12.2) | |
Not aware of HIV+ | 4 | 13.1 (0.5 to 25.8)† | 46 | 34.2 (24.4 to 43.9) | |
Total | 33 | 134 | |||
Viral load | 0.7177 | ||||
Aware of HIV+, on ART, suppressed‡ | 43 | 76.6 (67.3 to 85.8) | 103 | 74.5 (68.0 to 81.0) | |
Aware of HIV+, on ART, not suppressed | 13 | 23.4 (14.2 to 32.7) | 36 | 25.5 (19.0 to 32.0) | |
Total | 56 | 139 |
Eligibility for ART defined as CD4 ≤350 cells per microliter, prior history of tuberculosis, and ever taking ART.
Estimates based on sample sizes of <50 observations and may be unreliable.
HIV RNA concentration <1000 copies per milliliter.